Version 1
: Received: 28 February 2023 / Approved: 3 March 2023 / Online: 3 March 2023 (06:30:04 CET)
How to cite:
Maksimova, A.S.; Shelkovnikova, T.A.; Ryumshina, N.I.; Mochula, O.V.; Vaizov, V.K.; Trubacheva, I.A.; Novikova, O.M.; Naiman, A.B.; Kuznetsova, A.D.; Chesalov, N.P.; Ussov, W.Y.; Nina D. Anfinogenova, A. Epidemiology Aspects of Magnetic Resonance Imaging in the Context of COVID-19 Pandemic. Preprints2023, 2023030059. https://doi.org/10.20944/preprints202303.0059.v1.
Maksimova, A.S.; Shelkovnikova, T.A.; Ryumshina, N.I.; Mochula, O.V.; Vaizov, V.K.; Trubacheva, I.A.; Novikova, O.M.; Naiman, A.B.; Kuznetsova, A.D.; Chesalov, N.P.; Ussov, W.Y.; Nina D. Anfinogenova, A. Epidemiology Aspects of Magnetic Resonance Imaging in the Context of COVID-19 Pandemic. Preprints 2023, 2023030059. https://doi.org/10.20944/preprints202303.0059.v1.
Cite as:
Maksimova, A.S.; Shelkovnikova, T.A.; Ryumshina, N.I.; Mochula, O.V.; Vaizov, V.K.; Trubacheva, I.A.; Novikova, O.M.; Naiman, A.B.; Kuznetsova, A.D.; Chesalov, N.P.; Ussov, W.Y.; Nina D. Anfinogenova, A. Epidemiology Aspects of Magnetic Resonance Imaging in the Context of COVID-19 Pandemic. Preprints2023, 2023030059. https://doi.org/10.20944/preprints202303.0059.v1.
Maksimova, A.S.; Shelkovnikova, T.A.; Ryumshina, N.I.; Mochula, O.V.; Vaizov, V.K.; Trubacheva, I.A.; Novikova, O.M.; Naiman, A.B.; Kuznetsova, A.D.; Chesalov, N.P.; Ussov, W.Y.; Nina D. Anfinogenova, A. Epidemiology Aspects of Magnetic Resonance Imaging in the Context of COVID-19 Pandemic. Preprints 2023, 2023030059. https://doi.org/10.20944/preprints202303.0059.v1.
Abstract
The aim of study was to investigate epidemiology aspects of magnetic resonance imaging (MRI) during COVID-19 pandemic. The study comprised depersonalized residents of Tomsk and Tomsk Region (n = 1714). Invitations to take online survey were sent to 50,000 residents by target SMS with response rate of 1.2% (n = 727, Cohort 1). Cohort 2 comprised retrospective patients (n = 987) who underwent contrast-enhanced cardiac MRI (CMR) in 2019-2022. Referrals, clinical characteristics, diagnosis, gender, age, past COVID-19, MRI study protocols, and MRI data were analyzed. 29% of respondents in cohort 1 received MRI examination within past two years; 26% of respondents considered MRI the most informative imaging modality for detecting COVID-19 pneumonia; 12% of respondents reported MRI unavailable. Proportion of CMR among MRI studies increased during COVID-19 pandemic, and maximum incidence of cardiac diseases detected by MRI was in 2021. Incidence of myocardial fibrosis increased from ~67% in 2019 to ~84% in 2022. The rate of outpatient MRI studies significantly increased in 2020, but returned to pre-pandemic level in 2021. COVID-19 pandemic increased the need for MRI and CMR. Patients with history of COVID-19 had persistent and newly occurring symptoms of myocardial damage suggesting chronic cardiac involvement requiring continuous follow-up.
Keywords
COVID-19; long COVID-19; paramagnetic contrast-enhanced cardiac magnetic resonance imaging; MRI; CMR; myocarditis; electronic medical record; online survey; epidemiology; public health
Subject
MEDICINE & PHARMACOLOGY, Cardiology
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.